Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -35.92% is in line with its 5-year average of -35.32%, around the middle of its 5-year range (-56.54%–-19.82%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.99% above its 12-month average of -42.76%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -35.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-35.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-42.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-40.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-35.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.99%
CURRENT VS 3Y AVG
+10.33%
CURRENT VS 5Y AVG
-1.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.89%
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
-20.17%
vs the sector median at left
C4 Therapeutics, Inc.
Market Cap
$329.49M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-42.76%
3Y Avg
-40.06%
5Y Avg
-35.32%
Market Cap
$334.26M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$339.93M
Return on Invested Capital (ROIC)
-27.16%
TTM Avg
-54.52%
3Y Avg
-49.44%
5Y Avg
-51.83%
Market Cap
$318.27M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
Market Cap
$348.85M
Return on Invested Capital (ROIC)
17.99%
TTM Avg
23.20%
3Y Avg
26.35%
5Y Avg
40.47%
Market Cap
$311.25M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-35.80%
3Y Avg
-1011.32%
5Y Avg
-772.02%
Market Cap
$348.63M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$350.42M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$305.38M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $329.49M | -35.92% | -42.76% | -40.06% | -35.32% |
| Cabaletta Bio, Inc. (CABA)vs › | $334.26M | -85.56% | -114.55% | -77.72% | -63.50% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $339.93M | -27.16% | -54.52% | -49.44% | -51.83% |
| CapsoVision, Inc. (CV)vs › | $318.27M | -164.32% | -159.25% | -125.06% | -125.06% |
| Embecta Corp. (EMBC)vs › | $348.85M | 17.99% | 23.20% | 26.35% | 40.47% |
| Benitec Biopharma Inc. (BNTC)vs › | $311.25M | -28.88% | -35.80% | -1011.32% | -772.02% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $348.63M | -40.51% | -48.13% | -48.38% | -39.85% |
| Agenus Inc. (AGEN)vs › | $350.42M | N/A | -35.18% | -129.73% | -103.61% |
| Standard BioTools Inc. (LAB)vs › | $305.38M | -14.06% | -26.07% | -28.37% | -26.89% |
| Opus Genetics, Inc. (IRD)vs › | $359.16M | -59.29% | -166.84% | -79.03% | -92.27% |
ROIC
-35.9%
ROE
-41.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -35.92% |
| 2026-03-31 | -36.95% |
| 2025-12-31 | -35.34% |
| 2025-09-30 | -56.54% |
| 2025-06-30 | -49.04% |
| 2025-03-31 | -41.82% |
| 2024-12-31 | -39.29% |
| 2024-09-30 | -35.86% |
| 2024-06-30 | -36.37% |
| 2024-03-31 | -39.32% |
| 2023-12-31 | -41.67% |
| 2023-09-30 | -46.21% |
| 2023-06-30 | -42.89% |
| 2023-03-31 | -37.44% |
| 2022-12-31 | -33.34% |
| 2022-09-30 | -25.45% |
| 2022-06-30 | -21.98% |
| 2022-03-31 | -19.82% |
| 2021-12-31 | -22.54% |
| 2021-09-30 | -23.15% |
| 2021-06-30 | -20.73% |
| 2021-03-31 | -26.50% |
| 2020-12-31 | -16.97% |
| 2020-09-30 | -27.52% |
| 2020-06-30 | -20.52% |
| 2019-12-31 | -41.90% |
